Trial intelligence / Profile preview

Phase II trial of iguratimod versus nimesulide in rheumatoid arthritis

ChiCTR-TRC-10000849Phase 2Completed

Sponsor
Anhui Medical University
Start
Jul 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, double-blind trial of iguratimod in rheumatoid arthritis (RA) (2 arms), sponsored by Anhui Medical University. Primary endpoints: Morning stiffness, Pain and 4 more. Started Jul 2005; status: completed.

02

Drugs

iguratimod
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on ChiCTR-TRC-10000849.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10000849.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call